MedTrace Logo

Efficacy of Intramuscular Naloxone 0.4mg. in Prophylaxis of Intrathecal Morphine Induced Pruritus After Cesarean Section

NCT00890942 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2011-07-25

No results posted yet for this study

Summary

The purpose of this study is to determine whether intramuscular naloxone 0.4mg. is effective in prophylaxis of intrathecal morphine induced pruritus after cesarean section.

Conditions

  • Morphine Adverse Reaction

Interventions

DRUG

naloxone

naloxone 0.4mg.(1 ml) intramuscular

DRUG

normal saline

normal saline 1 ml IM

Sponsors & Collaborators

  • Mahidol University

    lead OTHER

Principal Investigators

  • Tachawan Jirativanont, MD · Anesthesiology department ,Siriraj hopital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2009-10-31
Completion
2010-05-31

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00890942 on ClinicalTrials.gov